The structures reveal that AMPA agonists with an isoxazole moiety adopt different binding modes in the receptor, dependent on the substituents of the isoxazole.
Given the issues identified with the reference agonist Mustard Oil (MO) in screening, a new, non-covalently binding agonist was optimized and proved to be a superior agent to MO for screening purposes.
Binding is rapid, reaching equilibrium in less than 17 minutes at 25 degrees C. Adrenergic agonists compete for this binding site with an order of affinities identical to the pharmacological potency order of these agents as alpha-adrenergic agonists (epinephrine greater than norepinephrine greater than isoprotereonl).
It is a highly potent α2 adrenergic agonist with a remarkable binding specificity for the α2 adrenoceptor.
Propylpyrazoletriol (PPT) has been described in the literature as an ERα selective agonist with a relative binding activity (RBA) of 49, (as compared to an RBA = 100 for estradiol), whereas the diarylpropionitrile compound (DPN) displays ERβ agonist selectivity (RBA = 18) [ 28, 29].
So, after agonist binding, the receptor is switched to the low-affinity state and kept in that state by arrestin; thus, theoretically the density of D2 receptors in the high-affinity state decreases after binding with an agonist that recruits arrestin.
DPN is an ERβ selective agonist with a 70-fold greater relative binding affinity and 170-fold greater relative potency in transcription assays for ERβ than ERα [ 32].
Optimization of the 2-substituent of the benzimidazole ring led to a series of agonists with subnanomolar binding affinity and moderate-to-high intrinsic activity relative to that of 5-HT.
In whole cell radioligand binding assays, the parent A1-receptor agonist, NECA, fully inhibited specific binding with a log KD value of −5.97 (see Table 2; Figure 3).
Some beautiful crystallographic studies of the ERα and ERβ ligand binding domains occupied with a range of agonists and antagonists were presented by Geoff Greene (The Ben May Institute for Cancer Research, Chicago, IL, USA), which emphasise further the importance of structural changes in receptor activation and inhibition.
